Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
CF Industries Holdings (CF): Can It Reach the Street-High $150 Price Target?

CF Industries Holdings (CF): Can It Reach the Street-High $150 Price Target?

Key Takeaways

  • CF Industries Holdings, Inc. (NYSE: CF) currently trades around $125, and the $150 price target represents the Street-high analyst forecast — about 20% above recent levels and roughly 9% above the stock's all-time high near $138.
  • The strongest bullish argument centers on tight global nitrogen supply, elevated fertilizer prices driven by geopolitical instability, and CF's structural cost advantage from low-cost U.S. natural gas feedstock.
  • The biggest obstacles include a consensus analyst rating of Hold, recent price-target cuts from several major firms, and the inherently cyclical nature of nitrogen fertilizer earnings — with fiscal 2027 EPS expected to decline by roughly 28%.
  • Key technical levels include the all-time high near $138 as major resistance, with psychological support around $100 and the 52-week low near $75.
  • The central takeaway: $150 is achievable under a sustained nitrogen upcycle, but the stock's powerful rally has already priced in considerable optimism, making further gains heavily dependent on continued supply disruptions and crop price strength.

Why the $150 Target Stands Out

Among the 19 to 21 analysts covering CF Industries Holdings, Inc. (CF), the $150 price target stands out as the most bullish call on Wall Street. Wells Fargo analyst Michael Sison reiterated an Overweight rating with this target in May 2026, and firms including Barclays and Freedom Capital Markets have set targets at $145 and $147 respectively — clustering just below the $150 threshold. For investors scanning the analyst landscape, $150 has become shorthand for the bull case, especially after the stock surged roughly 55% year-to-date in 2026 and touched an all-time high of approximately $138 in March.

A Quick Look at CF Industries

CF Industries is the world's largest ammonia producer and a leading global manufacturer of nitrogen-based products. Headquartered in Northbrook, Illinois, the company operates nine world-scale manufacturing complexes across the United States, Canada, and the United Kingdom, producing approximately 10 million tons of ammonia annually. Its product portfolio spans anhydrous ammonia, granular urea, urea ammonium nitrate (UAN), ammonium nitrate, and diesel exhaust fluid. Because CF manufactures nitrogen using low-cost U.S. natural gas as its primary feedstock, it ranks among the lowest-cost nitrogen producers globally — a structural advantage that underpins its profitability during commodity upcycles.

Factors Supporting a Move Higher

Several converging factors support the possibility of CF reaching $150. First, global nitrogen markets remain tight. Ongoing geopolitical tensions — particularly in the Middle East — have disrupted fertilizer supply chains and pushed nitrogen prices higher. Higher crop prices have simultaneously strengthened farmer purchasing power, supporting demand for nitrogen fertilizer during key planting seasons.

Second, CF's financial performance has been exceptional. First-quarter 2026 results showed net sales up 20% and earnings per share (EPS) nearly doubling year-over-year. The full-year 2026 EPS consensus sits at roughly $15.86, approximately 69% above the prior year. The company also announced a 20% dividend increase, signaling management confidence in cash generation.

Third, CF's valuation remains relatively modest. Even after the rally, the stock trades at a trailing price-to-earnings (P/E) ratio of roughly 11x — well below the broader U.S. chemicals industry average of approximately 24x. If nitrogen pricing remains elevated and the market assigns a higher multiple, a move toward $150 becomes mathematically plausible. A discounted cash flow analysis using free cash flow projections has suggested a fair value above $150 in certain scenarios. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Risks That Could Cap Gains

Despite the bullish narrative, significant headwinds could keep $150 out of reach. The most immediate concern is that much of the good news may already be priced in. With the stock up more than 55% year-to-date, the average analyst price target sits near $125 — essentially flat from current levels. Several major firms, including Morgan Stanley, Goldman Sachs, and UBS, trimmed their price targets during mid-2026, and the overall consensus rating across 19-plus analysts remains a cautious Hold.

The cyclical nature of nitrogen fertilizer earnings represents another major risk. While fiscal 2026 EPS is projected at $15.86, consensus estimates for fiscal 2027 point to a sharp decline toward approximately $11.36 — a drop of about 28%. Markets tend to price stocks on forward expectations, and if investors begin discounting a 2027 earnings contraction, the stock could struggle to sustain upward momentum.

An ongoing Department of Justice (DOJ) pricing probe into the fertilizer industry adds regulatory uncertainty. Additionally, any easing of geopolitical tensions or a meaningful decline in natural gas prices in competing regions like Europe or the Middle East could narrow CF's cost advantage and soften nitrogen prices.

Analyst Opinions Remain Mixed

The analyst community is notably split. Wells Fargo and Barclays maintain bullish stances, with targets at $150 and $145 respectively. Freedom Capital Markets upgraded CF to Buy with a $147 target in May 2026. Yet BofA Securities, Mizuho, and Rothschild & Co Redburn sit on the opposite side, with ratings of Underperform or Sell and price targets ranging from $72 to $106. This wide dispersion — from $72 on the low end to $150 on the high end — reflects genuine uncertainty about whether current nitrogen pricing strength can persist beyond the near term. The average target of roughly $125 suggests that, as a group, analysts see the stock as fairly valued at current levels.

Important Technical Levels to Watch

From a technical perspective, CF's all-time high near $138 serves as the most important resistance level. A decisive break above that level — ideally on above-average volume — would likely be required before $150 becomes a realistic near-term objective. On the downside, the $100 level has acted as an important psychological and structural support zone, reinforced by the stock's 52-week low near $75. The stock's rapid ascent from the high $70s to the mid-$130s means the intermediate support zones are less well-defined, which could contribute to heightened volatility during any pullback. From what I see, these levels remain key reference points for any position sizing decisions.

My Take on the Outlook

The question of whether CF Industries can reach $150 hinges on the durability of the current nitrogen upcycle. The bull case — tight global supply, favorable agricultural economics, low-cost U.S. natural gas, and a still-modest P/E multiple — provides a credible pathway to the Street-high target. However, the bear case is equally substantial: a consensus Hold rating, recent analyst downgrades and target cuts, projected earnings contraction in 2027, and a stock that has already absorbed enormous gains. For $150 to materialize, nitrogen prices would likely need to remain elevated well into 2027, geopolitical supply disruptions would need to persist, and the market would need to assign CF a higher earnings multiple than it currently does. Investors should watch nitrogen price trends, crop futures, geopolitical developments, and the DOJ probe as key indicators of whether the rally has further to run.

AI Tools in My Research Process

One resource I turn to when sorting through volatile names and mixed signals is Tickeron’s AI Daily Buy/Sell Signals. The platform applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and evolving market conditions. It helps me quickly cross-check ideas without manually reviewing every chart and report, which keeps the analysis process more efficient when evaluating opportunities like CF.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CF

CF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 18, 2026

CF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 33 cases where CF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CF's RSI Indicator exited the oversold zone, 17 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 58 cases where CF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.

Following a +1.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CF advanced for three days, in 245 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

The Aroon Indicator entered an Uptrend today. In 207 of 274 cases where CF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CF as a result. In 67 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for CF turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 37 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

CF moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CF crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.041) is normal, around the industry mean (2.504). P/E Ratio (8.569) is within average values for comparable stocks, (42.983). Projected Growth (PEG Ratio) (0.498) is also within normal values, averaging (0.867). Dividend Yield (0.018) settles around the average of (0.034) among similar stocks. P/S Ratio (2.667) is also within normal values, averaging (1.476).

The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. CF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 9.5B. The market cap for tickers in the group ranges from 611 to 51.87B. CTVA holds the highest valuation in this group at 51.87B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was -9%. For the same Industry, the average monthly price growth was -25%, and the average quarterly price growth was 27%. IPI experienced the highest price growth at 4%, while CTVA experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 210%. For the same stocks of the Industry, the average monthly volume growth was 186% and the average quarterly volume growth was 146%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 35
P/E Growth Rating: 60
Price Growth Rating: 65
SMR Rating: 80
Profit Risk Rating: 79
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
CF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of nitrogen fertilizer products

Industry ChemicalsAgricultural

Industry
Chemicals Agricultural
Address
2375 Waterview Drive
Phone
+1 847 405-2400
Employees
2900
Web
https://www.cfindustries.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.